Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands
about
Sigma receptors: potential targets for a new class of antidepressant drugThe sigma receptor: evolution of the concept in neuropsychopharmacologyNovel sigma (sigma) receptor agonists produce antidepressant-like effects in miceMonoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model StudySigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy.Anti-amnesic effect of dimemorfan in mice.Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan.Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodentsA Role for Sigma Receptors in Stimulant Self Administration and Addiction.4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugsSigma receptors [σRs]: biology in normal and diseased statesChanges in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.Sigma-1 receptor knockout mice display a depressive-like phenotype.The pharmacology of sigma-1 receptors.Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT.Pharmacology and therapeutic potential of sigma(1) receptor ligands.Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the BrainThe development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET).Medicinal Chemistry of σ1 Receptor Ligands: Pharmacophore Models, Synthesis, Structure Affinity Relationships, and Pharmacological Applications.Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.Synthesis, characterization, and metabolism studies of fluspidine enantiomers.Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.Sigma-1 Receptor and Neuronal Excitability.Synthesis, σ receptor affinity, and pharmacological evaluation of 5-phenylsulfanyl- and 5-benzyl-substituted tetrahydro-2-benzazepines.
P2860
Q24567770-2B4119BD-28DB-4164-8033-DCF408842076Q24651621-97E837F7-CA7B-47F1-A270-73E4500CE2ACQ28294148-883E5987-3205-4CAE-82B1-DC883E0D8157Q34342107-96EF3552-17A4-4E34-A912-3ED47C6AAE7FQ34362333-4669AD4C-473D-4A28-ABD8-2A082770D04FQ35045050-93862A44-BA77-41BC-848D-4799F49C720BQ35108500-8D6475AF-4F74-4FC1-A7D4-4681B33ED95EQ35176885-045667C5-CE6D-45A9-859C-EE4DF9E00CA4Q35197016-9B81E8A0-C5E9-4CB2-9084-E9E2EE79465FQ35812711-E3CC17DA-332B-48CE-BAB9-EAA1F1787F0FQ37000551-7BBA1A2B-0727-404B-B48C-49438004D0C0Q37097073-04890813-1E4D-4CB0-A0F3-B3AC4D3E50F0Q37155952-25E274F7-6CD3-435B-A331-A78E2BC38E4DQ37445561-F9010515-AA14-4AE7-A73E-D0138190568DQ37493467-87428268-A460-4B45-8F7D-852CEDF03A1EQ37545379-B8A72027-6FF7-407D-9D81-AC76EA897C08Q37559277-5E5D3C54-C321-463B-9B1C-94E8D069BE56Q38166977-2476E05D-05CB-4B0D-A740-E3D01C66A722Q38723014-D8FA7E11-7A23-47F8-A21E-42CCC9B08B22Q46280394-5E13F1F1-0773-4B8C-9666-6FC799FD5C3CQ46361348-2328B175-AAF8-4E82-B5FA-A2D60B5AE072Q46988486-F891F925-26AE-4107-9D8A-668C1E3181B3Q48272022-69AA890C-CBB9-4532-8DF0-F434D2E93993Q51076938-D3B5248F-06F8-4474-BF76-5811D99F9ED5
P2860
Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modulation of serotonergic neu ...... treatments with sigma ligands
@ast
Modulation of serotonergic neu ...... treatments with sigma ligands
@en
Modulation of serotonergic neu ...... treatments with sigma ligands
@nl
type
label
Modulation of serotonergic neu ...... treatments with sigma ligands
@ast
Modulation of serotonergic neu ...... treatments with sigma ligands
@en
Modulation of serotonergic neu ...... treatments with sigma ligands
@nl
prefLabel
Modulation of serotonergic neu ...... treatments with sigma ligands
@ast
Modulation of serotonergic neu ...... treatments with sigma ligands
@en
Modulation of serotonergic neu ...... treatments with sigma ligands
@nl
P2860
P356
P1476
Modulation of serotonergic neu ...... treatments with sigma ligands
@en
P2093
G Debonnel
J E Bermack
P2860
P356
10.1038/SJ.BJP.0704294
P407
P577
2001-10-01T00:00:00Z